Recent studies have highlighted a significant increase in weight of people living with HIV (PLWHIV) who began antiretroviral drugs, particularly integrase inhibitors. Aim of the present study was to assess if dolutegravir (DTG) was associated with weight gain in different antiretroviral regimens in a large observational cohort.
Weight gain in dolutegravir containing regimens in the observational SCOLTA cohort.
Pellicanò GF
;
2019-01-01
Abstract
Recent studies have highlighted a significant increase in weight of people living with HIV (PLWHIV) who began antiretroviral drugs, particularly integrase inhibitors. Aim of the present study was to assess if dolutegravir (DTG) was associated with weight gain in different antiretroviral regimens in a large observational cohort.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
